EU Panel Backs Eli Lilly’s Foundayo Weight-Loss Pill
A European Medicines Agency panel issued a positive opinion on Foundayo, also known as orforglipron, for weight management and type 2 diabetes, moving Eli Lilly closer to a European launch.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.